Everforth Inc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Everforth Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,440	2,626	3,400	3,416	3,502	4,010	4,581	4,451	4,100	3,980
Cost of revenue	1,645	1,776	2,376	2,444	2,555	2,867	3,212	3,171	2,916	2,831
Gross profit	795	850	1,024	972	947	1,142	1,370	1,280	1,184	1,149
Selling, general and administrative	566	592	705	645	615	736	895	844	821	854
Operating income	190	225	260	276	281	351	410	364	304	230
Interest expense	32.3	27.6	56	52.9	39.7	37.5	45.9	66.4	64.3	67.7
Pre-tax income	157	197	204	204	242	313	364	298	240	163
Income tax	60.2	39.2	46.2	54.7	63.9	81.6	96.7	78.4	64.9	49.1
Income from continuing operations	97.2	158	158	175	200	410	268	219	175	114
Net income	97.2	158	158	175	200	410	268	219	175	114
EBITDA	252	283	355	367	371	441	501	464	401	344
EPS, basic	1.83	3.01	3.02	3.31	3.80	7.78	5.30	4.54	3.88	2.62
EPS, diluted	1.81	2.97	2.98	3.28	3.76	7.66	5.23	4.50	3.83	2.60
Shares, basic (weighted)	53.2	52.5	52.3	52.8	52.7	52.7	50.6	48.3	45.2	43.4
Shares, diluted (weighted)	53.7	53.2	53.1	53.4	53.3	53.5	51.3	48.7	45.7	43.6

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	27.1	36.7	41.8	95.2	274	530	70.3	176	205	161
Receivables	387	429	614	649	603	708	854	742	651	674
Other current assets	3.29	3.03	4.3	18.2	17.3	30.4	17.3	19.1	61.7	80.6
Total current assets	438	500	686	792	994	1,309	981	973	918	916
Property, plant and equipment	56.9	58	79.1	73.7	54.9	55	66.3	81.4	82.6	84.5
Lease right-of-use assets			0	94.6	73	57.1	51.1	64.2	61.9	58
Goodwill	874	894	1,421	1,487	1,421	1,570	1,892	1,894	1,893	2,143
Intangible assets	378	353	489	477	470	488	570	498	440	454
Other non-current assets	6.96	5.75	12.6	18.2	20.6	23.9	25.6	33.7	95.8	79.6
Total assets	1,753	1,810	2,688	2,941	3,278	3,503	3,586	3,545	3,429	3,677
Accounts payable	6.27	6.87	43.1	39.2	38.3	20.1	35.2	34	27.2	47.2
Accrued liabilities	112	115	195	203	239	306	285	237	218	231
Deferred revenue									17.6	26.2
Total current liabilities	162	167	308	341	416	451	442	394	367	424
Long-term debt	640	575	1,100	1,032	1,033	1,034	1,067	1,037	1,034	1,169
Lease liabilities			0	75.7	55.4	40.2	32.3	49.1	46.9	41.5
Other non-current liabilities	6.59	7.37	17.3	17.6	65.9	23.4	14.4	16.7	64.2	42.3
Total liabilities	884	819	1,506	1,565	1,691	1,637	1,684	1,653	1,652	1,873
Total debt	640	575	1,100	1,032	1,033	1,034	1,067	1,037	1,034	1,169
Paid-in capital	563	566	602	638	661	691	704	696	684	714
Retained earnings	316	428	586	745	926	1,174	1,200	1,196	1,097	1,092
Other comprehensive income	-10	-3.64	-6.3	-7	-1	-0.3	-2.7	0	-5	-1.6
Shareholders' equity	869	991	1,182	1,376	1,587	1,865	1,901	1,892	1,777	1,804
Total equity	869	991	1,182	1,376	1,587	1,865	1,901	1,892	1,777	1,804
Total liabilities and equity	1,753	1,810	2,688	2,941	3,278	3,503	3,586	3,545	3,429	3,677
Shares outstanding	52.7	52.2	52.5	52.9	52.9	51.8	49.5	46.7	43.8	41.3

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	97.2	158	158	175	200	410	268	219	175	114
Depreciation and amortization	62.2	58.6	95	91.2	89.7	89.6	91.4	100	96.3	114
Stock-based compensation	27	24	31.5	39.3	32.3	52.7	49.3	44	42.3	47.9
Deferred income tax	12.7	-4.9	11.1	18.9	1.4	19.5	31.6	26.8	31.5	44.1
Change in receivables	-43.3	-50.5	-90.7	-24.3	-12.9	-111	-116	111	87	-3.8
Change in payables	-2.24	0.3	23.3	-7.3	0.8	-23.6	7.6	-2.4	-6.6	16.1
Cash from operations	199	196	287	313	425	194	308	457	400	328
Capital expenditures	-27.1	-24.3	-28.7	-32.7	-32.6	-34.7	-37.5	-39.9	-35.3	-39.8
Acquisitions	0	-25.9	-760	-116	-186	-223	-485	0	0	-304
Cash from investing	-22	-50.1	-789	-149	-219	247	-510	-40.5	-35.3	-344
Debt issued	11	37	822	653	65.5	0	94	572	0	421
Debt repaid	-129	-105	-286	-736	-65.5	0	-62.5	-597	-5	-282
Stock issued	0	0
Share buybacks	-41.1	-60.1	0	-20	-27.9	-181	-281	-273	-327	-170
Cash from financing	-174	-139	508	-111	-29	-184	-257	-311	-333	-29.4
Exchange rate effect	-0.11	1.8	-1.4	-0.2	2.4	-0.6	-0.6	0.1	-2.2	1.4
Net change in cash	3.18	9.62	5.1	53.4	179	255	-459	106	29.3	-44
Free cash flow	172	172	259	281	392	159	270	417	365	288
Interest paid	26.8	24.1	51	44.9	37.6	35.2	43.7	62.1	62.6	67
Income taxes paid	38.2	55.3	21.4	56.6	64.2	170	54.5	44.8	33.5	7.9

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $33.12 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	28.5%	Gross profit / revenue.
Operating margin	4.9%	Operating income / revenue.
EBITDA margin	7.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.1%	Pre-tax income / revenue.
Net margin	2.1%	Net income / revenue.
FCF margin	5.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.5%	Cash from operations / revenue.
Effective tax rate	31.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	4.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.1%	Net income / average total assets.
Return on invested capital (ROIC)	4.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	22.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.9%	Capital expenditures / revenue.
D&A / revenue	3.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-2.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	2.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-2.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-5.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-24.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-17.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-3.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-14.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-11.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-1.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-35.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-24.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-10.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-32.1%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-20.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-7.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-18.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	2.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-5.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-21.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	2.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-6.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	1.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-1.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	2.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	7.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	2.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-5.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-3.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.13x	Current assets / current liabilities.
Quick ratio	1.98x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.33x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.80x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	35.7%	Total debt / total assets.
Liabilities / assets	55.1%	Total liabilities / total assets.
Net debt	$1.29B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	4.13x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.69x	Operating income / interest expense.
Working capital	$523.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	71.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$1.07B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.99x	Revenue / average total assets.
Fixed asset turnover	50.2x	Revenue / average property, plant and equipment.
Receivables turnover	5.18x	Revenue / average receivables.
Days sales outstanding	71 days	365 x average receivables / revenue.
Days payables	9 days	365 x average accounts payable / cost of revenue.
FCF conversion	266.4%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	13.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.02	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$96.75	Revenue / diluted weighted shares.
FCF per share	$5.39	Free cash flow / diluted weighted shares.
Operating cash flow per share	$6.27	Cash from operations / diluted weighted shares.
Book value per share	$44.13	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$26.18	Tangible book value / shares outstanding.
Cash per share	$3.74	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	72.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.36B	Share price x shares outstanding.
Enterprise value	$2.64B	Market cap + total debt - cash - short-term investments.
P/E	16.4x	Market cap / net income. Only when net income is positive.
P/S	0.34x	Market cap / revenue.
P/B	0.75x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	6.14x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.29x	Market cap / cash from operations, when positive.
EV/Sales	0.67x	Enterprise value / revenue.
EV/EBIT	13.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	8.49x	Enterprise value / EBITDA, when both are positive.
EV/FCF	12.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	16.3%	Free cash flow / market cap.
Earnings yield	6.1%	Net income / market cap (the inverse of P/E).
Shareholder yield	11.8%	(Dividends paid + share buybacks) / market cap.

What was Everforth Inc's revenue in fiscal 2025?

Everforth Inc reported revenue of $3.98B for fiscal 2025, 2.9% lower than the year before.

Was Everforth Inc profitable in fiscal 2025?

Yes. Net income was $113.5M, a net margin of 2.9%.

How much free cash flow did Everforth Inc generate in fiscal 2025?

Cash from operations of $327.9M minus capital expenditures of $39.8M left free cash flow of $288.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Everforth Inc